Regulatory matters
Năm xuất bản : 1998
Chủ đề : 1. Adrenergic Uptake Inhibitors. 2. Antibodies, Monoclonal. 3. Antimalarials. 4. Australia. 5. Benzimidazoles -- pharmacology adverse effects supply and distribution. 6. Chlormezanone. 7. Chromans -- adverse effects supply and distribution. 8. Cyclobutanes -- chemistry. 9. Drug Approval -- pharmacology therapeutic use. 10. Drug Labeling -- supply and distribution adverse reactions. 11. European Union. 12. Fraud. 13. Germany. 14. Italy. 15. Japan. 16. Kenya. 17. Melatonin -- analysis. 18. New Zealand. 19. Nonprescription Drugs -- supply and distribution. 20. Pemoline -- administration and dosage. 21. Phenolphthaleins -- pharmacology adverse effects. 22. Piperidines -- adverse effects contraindications metabolism. 23. Scopolamine -- toxicity adverse effects supply and distribution. 24. Serotonin Uptake Inhibitors -- adverse effects contraindications metabolism. 25. Sweden. 26. Tetrahydronaphthalenes -- supply and distribution adverse effects. 27. Thiazoles -- adverse effects. 28. Triazoles. 29. United Kingdom. 30. United States. 31. Journal / periodical articles.
Thông tin dữ liệu nguồn
Thư viện | Ký hiệu xếp giá | Dữ liệu nguồn |
---|---|---|
Tổ chức y tế thế giới |
|
https://iris.who.int/handle/10665/55564 |